Jeff Schaffnit: Global Voices in Hemophilia Care at the World Federation of Hemophilia World Congress
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
“This week I had the privilege of joining the global hemophilia community at the World Federation of Hemophilia World Congress in Kuala Lampur, Malaysia.
The meeting was nothing short of inspiring—being in the room with clinicians, researchers, patient advocates and people living with hemophilia from around the world was a powerful reminder of why our work matters.
At Sanofi, we remain committed to advancing care for people with rare blood disorders, and moments like these continue to reinforce our team’s sense of urgency and purpose.
I’m grateful for the connections and conversations and look forward to what’s ahead.”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 11:57Dianne E. van der Wal: Red Blood Cell Engineering and the Role of Cytokine Glycosylation
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC